Open Journal of Psychiatry

Vol.2 No.4(2012), Paper ID 25113, 10 pages

DOI:10.4236/ojpsych.2012.224059

 

Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial

 

John M. Kane, Wolfgang Fleischhacker, Francesca Kolitsopoulos, Onur N. Karayal, Jamie Geier, Cynthia Siu, Robert Reynolds, Gerald Faich, Brian L. Strom

 

Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, USA
Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
Pfizer Inc., New York, USA
Pfizer Inc., New York, USA
Pfizer Inc., New York, USA
Data Power (DP), Inc., Ringoes, USA
Pfizer Inc., New York, USA
Department of Epidemiology, United BioSource Corporation, Blue Bell, USA
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, University of Pennsylvania School of Medicine, Philadelphia, USA

 

Copyright © 2012 John M. Kane, Wolfgang Fleischhacker, Francesca Kolitsopoulos, Onur N. Karayal, Jamie Geier, Cynthia Siu, Robert Reynolds, Gerald Faich, Brian L. Strom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Kane, J. , Fleischhacker, W. , Kolitsopoulos, F. , Karayal, O. , Geier, J. , Siu, C. , Reynolds, R. , Faich, G. and Strom, B. (2012) Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial. Open Journal of Psychiatry, 2, 423-432. doi: 10.4236/ojpsych.2012.224059.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.